Rifater and cytolytic hepatitis Patient Reports February 12, 2012

Rifater Side Effects Report #4852244-2
Rifater side effect was reported by a Consumer or non-health professional from on Sept 13, 2005. Male patient, 29 years of age, weighting 145.5 lb, was diagnosed with lymph node tuberculosis and was treated with Rifater. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, blood alkaline phosphatase increased, blood bilirubin increased, cytolytic hepatitis, eosinophilia, hepatic failure, hepatic trauma. Rifater dosage: unknown. Patient was hospitalized. Patient recovered.

Rifater Side Effects Report #4884948-X
Rifater side effect was reported by a Consumer or non-health professional from on Sept 13, 2005. Male patient, 29 years of age, weighting 145.5 lb, was diagnosed with lymph node tuberculosis and was treated with Rifater. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, blood alkaline phosphatase increased, blood bilirubin increased, cytolytic hepatitis, eosinophilia, hepatic failure, lipase increased. Rifater dosage: unknown. Patient was hospitalized. Patient recovered.

Rifater Side Effects Report #4895447-3
Rifater side effect was reported by a Consumer or non-health professional from on Sept 13, 2005. Male patient, 29 years of age, weighting 145.5 lb, was diagnosed with lymph node tuberculosis and was treated with Rifater. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, blood alkaline phosphatase increased, blood bilirubin increased, cytolytic hepatitis, eosinophilia, hepatic failure, lipase increased. Rifater dosage: unknown. Patient was hospitalized. Patient recovered.

Rifater Side Effects Report #5091676-7
Rifater side effect was reported by a Consumer or non-health professional from on Aug 21, 2006. Female patient, 48 years of age, was diagnosed with dermo-hypodermitis, urinary tract infection , irritable bowel syndrome  and was treated with Rifater. After drug was administered, patient experienced the following side effects: cytolytic hepatitis, dermatitis exfoliative, eosinophilia, hypersensitivity, lymphadenopathy, pyrexia, systemic inflammatory response syndrome, transaminases increased. Rifater dosage: unknown. During the same period patient was treated with NOROXIN, DEBRIDAT, MOTILIUM, SPASFON. Patient was hospitalized. Patient recovered.